Alendronate therapy to prevent loosening of, or pain associated

Details Alendronate therapy to prevent loosening of, or pain associated Alendronate therapy to prevent loosening of, or pain associated

1997-06-16

1999-04-06

Criares, Theodore J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

A61K 3166

Patent

active

058918639

ABSTRACT:
Disclosed is a therapy for treating and for preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an orthopedic implant device.

REFERENCES:
patent: 4753652 (1988-06-01), Langer et al.
patent: 5270365 (1993-12-01), Gertz et al.
patent: 5646134 (1997-07-01), Yates
Finerman, et al., 1981, Metabolic Bone Disease & Related Res. 3(4&5): 337-42.
(Abstract) Passeri, M., 1992, Ann. Ital. Med. Int. 7 (3 Suppl.):137S-153S.
Dustmann et al., 1988, Z. Orthop. 126(3):314-25.
Suva et al., Journal of Bone and Mineral Res., vol. 8, No. 3, pp. 379-388 (1993).

Affiliated with

Also associated with

Rating

Alendronate therapy to prevent loosening of, or pain associated does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alendronate therapy to prevent loosening of, or pain associated , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alendronate therapy to prevent loosening of, or pain associated will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1371479